Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

818.93 -10.81 (-1.30%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy 
Via MarketBeat
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany's healthcare sector. Recent investments by Daiichi Sankyo and Eli Lilly... 
Via Benzinga
Insights Into Eli Lilly and Co's Performance Versus Peers In Pharmaceuticals Sector
Via Benzinga
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. 
Via MarketBeat
Exposures Product Safety
Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
Eli Lilly is up a remarkable 97.38% over the past year and 55.32% year-to-date. Strong technical indicators suggest continued momentum. 
Via Benzinga
Is Google Stock A Buy With Earnings Due, New CFO Waiting In The Wings?
Up big in 2024 on AI buzz, Google reports earnings in July with a new CFO set to take over. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
Several AI stocks among the S&P 500's best performers. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
These stalwart companies could help you safely grow your wealth. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy in June
Healthcare businesses tend to hold up through various economic cycles. 
Via The Motley Fool
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments. 
Via InvestorPlace
This Is Massive News for Eli Lilly Investors
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate. 
Via The Motley Fool
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
First Half 2024 -- That's A Wrap
With the first half of 2024 now behind us, here is a snapshot of asset class performance across the financial landscape using US-listed ETFs and other exchange-traded products. 
Via Talk Markets
Topics ETFs
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs. 
Via InvestorPlace
The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
These healthcare stocks have clear paths to growth over the next few years. 
Via The Motley Fool
Stock Split Watch: Is Eli Lilly Next?
Eli Lilly's revenue has climbed, thanks to high demand for its weight loss drugs. 
Via The Motley Fool
AI Play Arista Networks At All-Time High, Leads List Of Newcomers To IBD Top Stock Lists Like IBD 50, Other Premium Lists
Arista Networks' EPS growth ranged up to 49% over the past four quarters. It was among nine stocks added to IBD top stock lists Thursday. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the world's most populous country. The competitive landscape and regulatory... 
Via Benzinga
3 Promising Stocks That Can Turn $10K Into $1 Million
$10,000 dollars invested in these high-growth stocks can legitimately grow into one million with shorter timelines than expected overall. 
Via InvestorPlace
7 A-Rated Stocks for Your June Buy List
While there's no bad time to buy A-rated stocks, these equities represent companies that are must-own picks for June 2024. 
Via InvestorPlace
3 Valuable Stocks That Are Worth the Expensive Price Tag
Putting your hard-earned money into the stock market? Here are expensive stocks worth buying for the long-term. 
Via InvestorPlace
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Active Fund Managers Bet These 6 Stocks Will Trade Near All-Time Highs
Active fund managers making large bets on momentum plays indicate confidence that Big Tech's rally has legs for the remainder of 2024. 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.